Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1996 2
1999 3
2000 2
2001 4
2005 1
2008 1
2009 2
2010 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.
Aller AI, Martin-Mazuelos E, Lozano F, Gomez-Mateos J, Steele-Moore L, Holloway WJ, Gutiérrez MJ, Recio FJ, Espinel-Ingroff A. Aller AI, et al. Among authors: steele moore l. Antimicrob Agents Chemother. 2000 Jun;44(6):1544-8. doi: 10.1128/AAC.44.6.1544-1548.2000. Antimicrob Agents Chemother. 2000. PMID: 10817706 Free PMC article.
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ; ARTEMIS DISK Global Antifungal Surveillance Group. Pfaller MA, et al. Diagn Microbiol Infect Dis. 2009 Sep;65(1):27-34. doi: 10.1016/j.diagmicrobio.2009.05.007. Diagn Microbiol Infect Dis. 2009. PMID: 19679232
Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
Vazquez JA, Sobel JD, Peng G, Steele-Moore L, Schuman P, Holloway W, Neaton JD. Vazquez JA, et al. Among authors: steele moore l. Clin Infect Dis. 1999 May;28(5):1025-31. doi: 10.1086/514746. Clin Infect Dis. 1999. PMID: 10452629 Clinical Trial.
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M; Global Antifungal Surveillance Group. Pfaller MA, et al. Diagn Microbiol Infect Dis. 2010 Jun;67(2):162-71. doi: 10.1016/j.diagmicrobio.2010.01.002. Epub 2010 Mar 24. Diagn Microbiol Infect Dis. 2010. PMID: 20338711
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi M; Global Antifungal Surveillance Group. Pfaller MA, et al. J Clin Microbiol. 2009 Jan;47(1):117-23. doi: 10.1128/JCM.01747-08. Epub 2008 Nov 12. J Clin Microbiol. 2009. PMID: 19005141 Free PMC article.
19 results